Engineering antigen-specific primary human NK cells against HER-2 positive carcinomas (Q36970863)
scholarly article
Language:
(P31) (Q13442814)
(P50) (Q41175830)
(Q64699149)
(Q88457780)
(Q74522749)
(P304) 17481-17486
(P407) (Q1860)
(P433) 45
(P478) 105
(P577) Wednesday, November 5, 2008
(P1433) (Q1146531)
(P1476) "Engineering antigen-specific primary human NK cells against HER-2 positive carcinomas" (language: en)
(P2093) Anna Kruschinski
Isabel Poschke
Markus Chmielewski
Rolf Kiessling
Thomas Blankenstein
Hinrich Abken
(P2860) (Q24644774)
(Q24647928)
(Q36652207)
(Q36652192)
(Q36652187)
(Q36652166)
(Q36652140)
(Q36645388)
(Q36578355)
(Q36567962)
(Q40257828)
(Q36494742)
(Q40427479)
(Q29615107)
(Q35847820)
(Q36327125)
(Q29619483)
(Q40483180)
(Q35875271)
(Q40616262)
(Q34267775)
(Q36471584)
(Q24551158)
(Q40714461)
(Q34726004)
(Q33944680)
(Q37509338)
(Q27824766)
(Q33829853)
(Q33885931)
(Q36719911)
(Q36470726)
(Q29619728)
(Q29547699)
(Q41642411)
(Q54432520)
(Q43987907)
(Q47299684)
(Q43760313)
(Q54071743)
(Q56906647)
(Q79748462)
(Q73850203)
(Q78464182)
other details